Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

NCT02101138 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

NIH

Sponsor class

Conditions

Hypereosinophilic Syndrome

Interventions

DRUG: Dexpramipexole

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]